Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Jm, Bachaud"'
Publikováno v:
Journal de radiologie. 83(1)
To assess by MRI, using a pelvic phased array coil, the accuracy for staging prostate carcinoma and to correlate the results with the rate of positive surgical margins.Between January 1995 and December 1999, 176 patients with localized prostate carci
Publikováno v:
Europe PubMed Central
The temporal fasciocutaneous scalp flap (TFSF) is used as mucosal reconstruction in 22 oropharyngeal and oral carcinomas. The anatomical basis of the flap and the clinical observations are described. The qualities of such a flap clearly appear: high
Publikováno v:
Europe PubMed Central
Three cases of non-Hodgkin malignant lymphoma (LMNH in text) of the mandible are described, and findings compared with those reported in the literature. The mean age of patients was 46 years, without any significant male preponderance (sex ratio: 1.1
Publikováno v:
European Journal of Cancer. 29:S171
Autor:
Bauvin E, Molinier L, Dervaux B, Soulié M, Latorzeff I, Jm, Bachaud, Villers A, Elias A, pascale grosclaude
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::35a58b16bc3f922cc3d7f0fe1193d5ba
http://europepmc.org/abstract/med/14650293
http://europepmc.org/abstract/med/14650293
Autor:
de Crevoisier R; Department of Radiotherapy, Centre Eugène Marquis, LTSI INSERM 1099, Rennes, France. Electronic address: r.de-crevoisier@rennes.unicancer.fr., Bayar MA; Department of Biostatistics, Gustave-Roussy Institute, Villejuif, France; CESP, Faculté de médecine, Université Paris-Sud, Faculté de médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France., Pommier P; Department of Radiotherapy, Léon Bérard Cancer Center, Lyon, France., Muracciole X; Department of Radiotherapy, de la Timone Hospital, Marseille, France., Pêne F; Department of Radiotherapy, Tenon Hospital, Paris, France; Clinique Hartmann, Levallois-Perret, France., Dudouet P; Department of Radiotherapy, Clinique du Pont de Chaume Clinic, Montauban, France., Latorzeff I; Department of Radiotherapy, Clinique Pasteur, Toulouse, France., Beckendorf V; Department of Radiotherapy, Alexis Vautrin Center, Vandoeuvre les Nancy, France., Bachaud JM; Department of Radiotherapy, Institut Claudius Regaud, Toulouse, France., Laplanche A; Department of Biostatistics, Gustave-Roussy Institute, Villejuif, France., Supiot S; Department of Radiotherapy, Institut de Cancérologie de l'Ouest, Saint Herblain, France., Chauvet B; Department of Radiotherapy, Sainte Catherine Institute, Avignon, France., Nguyen TD; Department of Radiotherapy, Jean-Godinot Institute, Reims, France., Bossi A; Department of Radiotherapy, Gustave-Roussy Institute, Villejuif, France., Créhange G; Department of Radiotherapy, Georges-François Leclerc Center, Dijon, France., Lagrange JL; Department of Radiotherapy, APHP Henri Mondor Hospital, UPEC Créteil, France.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2018 Dec 01; Vol. 102 (5), pp. 1420-1429. Date of Electronic Publication: 2018 Jul 31.
Autor:
Graff P; Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, Toulouse, France. Electronic address: graff-cailleaud.pierre@iuct-oncopole.fr., Portalez D; Department of Radiology, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Lusque A; Department of Biostatistics, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Brun T; Department of Biophysics, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Aziza R; Department of Radiology, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Khalifa J; Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Roumiguié M; Department of Urology, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Quintyn Ranty ML; Department of Pathology, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Filleron T; Department of Biostatistics, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Bachaud JM; Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Malavaud B; Department of Urology, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2018 Nov 15; Vol. 102 (4), pp. 903-911. Date of Electronic Publication: 2018 Feb 02.
Autor:
Brun T; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, Department of Engineering and Medical Physics, Toulouse, France. Electronic address: brun.thomas@iuct-oncopole.fr., Bachaud JM; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, Department of Radiotherapy, Toulouse, France., Graff-Cailleaud P; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, Department of Radiotherapy, Toulouse, France., Malavaud B; Centre Hospitalier Universitaire de Rangueil, Department of Urology, Toulouse, France., Portalez D; Centre Hospitalier Universitaire de Rangueil, Department of Urology, Toulouse, France; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, Department of Medical Imaging, Toulouse, France., Popotte C; Université Paul Sabatier, Toulouse III, Toulouse, France., Aziza R; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, Department of Medical Imaging, Toulouse, France., Lusque A; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, Clinical Trials Office, Toulouse, France., Filleron T; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, Clinical Trials Office, Toulouse, France., Ken S; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopôle, Department of Engineering and Medical Physics, Toulouse, France.
Publikováno v:
Brachytherapy [Brachytherapy] 2018 May - Jun; Vol. 17 (3), pp. 544-555. Date of Electronic Publication: 2018 Mar 07.
Autor:
Vaysse C; Surgery Oncology Department, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Faculté de Médecine, Université Paul Sabatier Toulouse III, Toulouse, France., Chantalat E; Surgery Oncology Department, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Faculté de Médecine, Université Paul Sabatier Toulouse III, Toulouse, France., Beyne-Rauzy O; Faculté de Médecine, Université Paul Sabatier Toulouse III, Toulouse, France.; Department of Internal Medicine, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Morineau L; Pôle Hospitalo-Universitaire en Cancérologie, Cancer Pharmacology of Toulouse-Oncopole and Region (Work Package 4 Research Program), Institut Universitaire du Cancer de Toulouse-Oncopole, Université Paul Sabatier Toulouse III, Toulouse, France., Despas F; Faculté de Médecine, Université Paul Sabatier Toulouse III, Toulouse, France.; Medical and Clinical Pharmacology Unit, Centre Hospitalier Universitaire de Toulouse, Toulouse, France., Bachaud JM; Radiotherapy Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Caunes N; Support Care Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Poublanc M; Clinical Research Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Serrano E; Faculté de Médecine, Université Paul Sabatier Toulouse III, Toulouse, France.; Pôle Hospitalo-Universitaire en Cancérologie, Cancer Pharmacology of Toulouse-Oncopole and Region (Work Package 4 Research Program), Institut Universitaire du Cancer de Toulouse-Oncopole, Université Paul Sabatier Toulouse III, Toulouse, France., Bugat R; Pôle Hospitalo-Universitaire en Cancérologie, Cancer Pharmacology of Toulouse-Oncopole and Region (Work Package 4 Research Program), Institut Universitaire du Cancer de Toulouse-Oncopole, Université Paul Sabatier Toulouse III, Toulouse, France., Rougé Bugat ME; General Practice Department, Université Paul Sabatier Toulouse III, Toulouse, France., Fize AL; Pôle Hospitalo-Universitaire en Cancérologie, Cancer Pharmacology of Toulouse-Oncopole and Region (Work Package 4 Research Program), Institut Universitaire du Cancer de Toulouse-Oncopole, Université Paul Sabatier Toulouse III, Toulouse, France.
Publikováno v:
JMIR medical education [JMIR Med Educ] 2018 Mar 05; Vol. 4 (1), pp. e6. Date of Electronic Publication: 2018 Mar 05.
Autor:
Bachaud JM; Département de radiothérapie, institut Claudius Regaud, 20-24, rue du Pont-Saint-Pierre, 31052 Toulouse, France. Electronic address: bachaud.jean-marc@claudiusregaud.fr., Latorzeff I, Soulié M
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2013 Dec; Vol. 17 (8), pp. 778-84; quiz 786, 789. Date of Electronic Publication: 2013 Nov 21.